ArticleThe Journal of biological chemistry2016

Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.

Brett M McGettigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.